Results 21 to 30 of about 48,999 (225)

Enzyme Preparations of the Pancreas without Enteric Coating: Whether they are Used Today?

open access: yesGastroenterologìa, 2014
Introduction. For the treatment of exocrine pancreatic insufficiency (EPI) it is recommended enzyme replacement therapy with high-dose enteric-coated preparations.
A.V. Savustyanenko
doaj   +1 more source

Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products. [PDF]

open access: yes, 2011
The use of compendial pH 6.8 phosphate buffer to assess dissolution of enteric coated products gives rise to poor in vitro-in vivo correlations because of the inadequacy of the buffer to resemble small intestinal fluids.
Abdul W. Basit   +44 more
core   +1 more source

Development and Comparison of Various Coated Hard Capsules Suitable for Enteric Administration to Small Patient Cohorts

open access: yesPharmaceutics, 2022
Pharmaceutical technology offers several options for protecting substances from acidic environments, such as encapsulation in enteric capsules or dosage form with enteric coating.
Nicole Fülöpová   +4 more
doaj   +1 more source

Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution

open access: yesPharmaceutics, 2022
Niclosamide is an FDA-approved anthelmintic that is being studied in clinical trials as a chemotherapeutic and broad-spectrum antiviral. Additionally, several other applications are currently in the preclinical stage.
Miguel O. Jara   +7 more
doaj   +1 more source

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. [PDF]

open access: yes, 2006
BACKGROUND AND PURPOSE: Aspirin resistance may be relatively common and associated with adverse outcome. Meta-analysis has clearly shown that 75 mg plain aspirin is the lowest effective dose; however, it is not known whether the recent increased use of ...
Byrne, Michael F   +5 more
core   +1 more source

Alendronate Sodium as Enteric Coated Solid Lipid Nanoparticles; Preparation, Optimization, and In Vivo Evaluation to Enhance Its Oral Bioavailability. [PDF]

open access: yesPLoS ONE, 2016
Treatment of osteoporosis with alendronate sodium has several challenges. The first challenge is the low bioavailability. The second main challenge is side effects, which include oesophageal ulceration.
Khaled Mohamed Hosny
doaj   +1 more source

Development of Enteric-coated Tablets of Sodium 4,4'-(propnadiamido)dibenzoate

open access: yesРазработка и регистрация лекарственных средств, 2022
Introduction. Enteric coat have a wide range of functions: from protecting the API from the adverse effects of the acidic environment of the stomach to targeted delivery to certain parts of the intestine in order to increase the effectiveness of the drug.
Ju. M. Kotsur   +2 more
doaj   +1 more source

Characterization of monoclonal and polyclonal antibodies to bovine enteric coronavirus: Establishment of an efficient ELISA for antigen detection in feces [PDF]

open access: yes, 1989
Monoclonal antibodies to bovine enteric coronavirus (BEC) were produced. Additionally, polyclonal antibodies were made in rabbits and guinea pigs and extracted from the yolk of immunized hens.
Czerny, C. P., Eichhorn, Werner
core   +1 more source

Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate [PDF]

open access: yes, 2012
Halitosis due to dimethylsulfide (DMS) generation is a major side effect of cysteamine in the treatment of cystinosis. Recently, an enteric coated formulation of cysteamine bitartrate (RP103) administered twice daily was demonstrated to be non-inferior ...
Besouw, Martine   +4 more
core   +1 more source

Clinical Efficacy and Residue Depletion of 10% Enrofloxacin Enteric-Coated Granules in Pigs

open access: yesFrontiers in Pharmacology, 2017
A new, more palatable formulation of 10% enrofloxacin enteric-coated granules was investigated to evaluate the pharmacokinetic effect in plasma, the residue elimination in tissues and the clinical efficacy against Actinobacillus pleuropneumonia (APP) and
Zhixin Lei   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy